Access Restriction

Author Liu, Lin ♦ Zhao, Tian Li ♦ Yang, Yi Feng ♦ Wang, Xin ♦ Ying, Ni ♦ Wu, Qin ♦ Gao, Nei
Source World Health Organization (WHO)-Global Index Medicus
Content type Text
Publisher Wiley
File Format HTM / HTML
Language English
Difficulty Level Medium
Subject Domain (in DDC) Natural sciences & mathematics ♦ Life sciences; biology ♦ Physiology & related subjects ♦ Natural history of organisms ♦ Technology ♦ Medicine & health ♦ Human anatomy, cytology, histology ♦ Human physiology ♦ Pharmacology and therapeutics ♦ Diseases ♦ Surgery & related medical specialties ♦ Manufacture for specific uses ♦ Precision instruments & other devices
Subject Domain (in MeSH) Cardiovascular System ♦ Anatomy ♦ Eukaryota ♦ Organisms ♦ Cardiovascular Diseases ♦ Diseases ♦ Diagnosis ♦ Therapeutics ♦ Surgical Procedures, Operative ♦ Investigative Techniques ♦ Equipment and Supplies ♦ Analytical, Diagnostic and Therapeutic Techniques and Equipment ♦ Physical Phenomena ♦ Biological Sciences ♦ Persons ♦ Persons
Subject Keyword Discipline Cardiology ♦ Discipline Surgery ♦ Cardiac Surgical Procedures ♦ Methods ♦ Heart Septal Defects, Ventricular ♦ Surgery ♦ Septal Occluder Device ♦ Aortic Valve ♦ Child ♦ Child, Preschool ♦ Echocardiography, Transesophageal ♦ Female ♦ Follow-up Studies ♦ Humans ♦ Logistic Models ♦ Male ♦ Surgery, Computer-assisted ♦ Time Factors ♦ Treatment Outcome ♦ Evaluation Studies ♦ Journal Article
Abstract OBJECTIVES: To evaluate the safety and the indication for percardiac device closure of subaortic ventricular septal defects (VSDs) under guidance of transesophageal echocardiography. METHODS: A total of 62 patients with VSDs immediately below the aortic valve underwent percardiac device closure without cardiopulmonary bypass. RESULTS: There were no deaths. Of 62 patients, 52 (83.9%) underwent successful closure and 10 (16.1%) were converted to open-heart surgery due to tricuspid regurgitation, aortic regurgitation, and a residual shunt. Multiple logistic regression analysis showed the type and diameter of VSD were associated with the failure of device closure. There were no severe adverse events. Follow-up ranged from 13 to 31 months (mean, 22.3 ± 5.2 months). Early and late complications occurred in 10 patients (19.2%) and two patients (3.8%), respectively. CONCLUSIONS: Excellent short-term results can be achieved in selected patients with percardiac device closure of subaortic ventricular septal defects.
Description Country affiliation: China
Author Affiliation: Liu L ( The Stomatology Center, The Second Xiang Ya Hospital, Central South University, Changsha, Hunan, PR, China.)
ISSN 08860440
Educational Role Student ♦ Teacher
Age Range above 22 year
Educational Use Reading ♦ Research ♦ Self Learning
Interactivity Type Expositive
Education Level UG and PG
Learning Resource Type Article
Publisher Date 2013-07-01
Publisher Place United States
e-ISSN 15408191
Journal Journal of Cardiac Surgery
Volume Number 28
Issue Number 4

Open content in new tab

   Open content in new tab
Source: WHO-Global Index Medicus